MorphoSys (MOR) Stock Chart & Stock Price History → Dave Ramsey Shocks Millions With US Dollar Lunacy (From American Hartford Gold Group) (Ad) Free MOR Stock Alerts €67.00 0.00 (0.00%) (As of 05/10/2024 ET) Add Compare Share Share ChartStock AnalysisChartHeadlinesStock AnalysisChartHeadlines MorphoSys Stock Price Performance5 Day Performance+0.37%1 Month Performance-1.40%3 Month Performance+3.88%6 Month Performance+131.03%Year-To-Date Performance+97.06%1 Year Performance+216.04% Receive MOR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter Email Address Ad American Hartford Gold GroupDave Ramsey Shocks Millions With US Dollar LunacyDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE MOR Stock Chart for Monday, May, 13, 2024 MOR Chart by TradingView MorphoSys Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/10/2024€66.75€67.00+0.37%€67.00€66.7077,473 shs$2.53 billion05/09/2024€66.75€66.75€67.20€66.50106,985 shs$2.52 billion05/08/2024€66.80€66.75-0.07%€67.20€66.50106,985 shs$2.52 billion05/07/2024€66.65€66.80+0.23%€67.05€66.6556,424 shs$2.52 billion05/06/2024€66.65€66.65€67.00€66.0072,984 shs$2.51 billion05/03/2024€66.20€66.65+0.68%€67.00€66.0072,984 shs$2.51 billion Get the Latest News and Ratings for MOR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter. 05/02/2024€66.20€66.20€67.00€65.50357,848 shs$2.50 billion05/01/2024€65.65€66.20+0.84%€67.00€65.50357,848 shs$2.50 billion04/30/2024€67.85€65.65-3.24%€67.30€65.201.20 million shs$2.47 billion04/29/2024€67.85€67.85€67.85€67.7539,191 shs$2.55 billion04/26/2024€67.70€67.75+0.07%€67.80€67.7056,527 shs$2.55 billion04/25/2024€67.75€67.70-0.07%€67.75€67.7063,222 shs$2.55 billion04/24/2024€67.75€67.75€67.90€67.7055,900 shs$2.55 billion04/23/2024€67.70€67.75+0.07%€67.85€67.70131,745 shs$2.55 billion04/22/2024€67.70€67.70€67.70€67.7059,669 shs$2.55 billion04/19/2024€67.70€67.70€67.80€67.70139,698 shs$2.55 billion04/18/2024€67.70€67.70€67.85€67.65122,121 shs$2.55 billion04/17/2024€67.95€67.70-0.37%€68.00€67.601.41 million shs$2.55 billion04/16/2024€67.95€67.95€68.00€67.851.73 million shs$2.55 billion04/15/2024€67.95€67.95€68.00€67.552.16 million shs$2.55 billion04/12/2024€67.15€67.60+0.67%€67.60€67.10286,198 shs$2.54 billion04/11/2024€67.05€67.15+0.15%€67.20€67.05142,594 shs$2.52 billion04/10/2024€67.00€67.05+0.07%€67.10€66.8590,725 shs$2.52 billion04/09/2024€67.05€67.00-0.07%€67.20€67.0070,732 shs$2.52 billion04/08/2024€67.05€67.05€67.25€67.05210,216 shs$2.52 billion04/05/2024€67.25€67.20-0.07%€67.25€67.10141,744 shs$2.53 billion04/04/2024€67.25€67.25€67.35€67.2096,708 shs$2.53 billion04/03/2024€67.20€67.25+0.07%€67.30€67.15111,409 shs$2.53 billion04/02/2024€67.20€67.20€67.24€67.20100,985 shs$2.53 billion04/01/2024€67.20€67.20€67.24€67.20100,985 shs$2.53 billion03/29/2024€67.20€67.20€67.24€67.20100,985 shs$2.53 billion03/28/2024€67.22€67.20-0.03%€67.26€67.1884,006 shs$2.53 billion03/27/2024€67.16€67.22+0.09%€67.24€67.16138,582 shs$2.53 billion03/26/2024€67.16€67.16€67.24€67.12169,514 shs$2.53 billion03/25/2024€67.18€67.16-0.03%€67.24€67.12169,514 shs$2.53 billion03/22/2024€66.32€66.32€66.50€66.2885,531 shs$2.49 billion03/21/2024€66.50€66.32-0.27%€66.50€66.2885,531 shs$2.49 billion03/20/2024€66.40€66.50+0.15%€66.50€66.20108,140 shs$2.50 billion03/19/2024€66.40€66.40€66.64€65.82173,645 shs$2.50 billion03/18/2024€66.40€66.40€66.64€65.82173,645 shs$2.50 billionDoes this make you sick? (Ad)The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit03/15/2024€66.30€66.04-0.39%€66.40€65.70110,629 shs$2.48 billion03/14/2024€66.10€66.30+0.30%€66.82€66.28173,268 shs$2.49 billion03/13/2024€65.52€66.10+0.89%€66.70€65.50198,162 shs$2.49 billion03/12/2024€65.30€65.52+0.34%€65.60€65.1889,805 shs$2.46 billion03/11/2024€65.30€65.30€65.44€65.1667,011 shs$2.46 billion03/08/2024€65.24€65.30+0.09%€65.44€65.1667,011 shs$2.46 billion03/07/2024€65.24€65.24€65.48€65.20118,455 shs$2.45 billion03/06/2024€65.24€65.24€65.38€65.10109,081 shs$2.45 billion03/05/2024€65.50€65.24-0.40%€65.38€65.10109,081 shs$2.45 billion03/04/2024€65.50€65.50€65.58€65.02112,698 shs$2.46 billion03/01/2024€65.12€65.50+0.58%€65.58€65.02112,698 shs$2.46 billion02/29/2024€65.16€65.12-0.06%€65.34€64.74203,536 shs$2.45 billion02/28/2024€65.10€65.16+0.09%€65.52€65.02146,680 shs$2.45 billion02/27/2024€65.52€65.10-0.64%€65.54€65.10226,089 shs$2.45 billion02/26/2024€65.52€65.52€65.58€65.00189,714 shs$2.46 billion02/23/2024€65.34€65.20-0.21%€65.58€65.06231,425 shs$2.45 billion02/22/2024€65.40€65.34-0.09%€65.66€65.22196,822 shs$2.46 billion02/21/2024€65.40€65.40€65.70€65.08282,332 shs$2.46 billion02/20/2024€65.48€65.40-0.12%€65.70€65.08282,332 shs$2.46 billion02/19/2024€65.44€65.48+0.06%€65.60€65.32166,358 shs$2.46 billion02/16/2024€65.60€65.60€65.98€64.92221,605 shs$2.47 billion02/15/2024€64.88€65.60+1.11%€65.98€64.92221,605 shs$2.47 billion02/14/2024€64.50€64.88+0.59%€64.88€64.20321,159 shs$2.44 billion02/13/2024€64.50€64.50€64.56€63.90292,271 shs$2.42 billion02/12/2024€64.10€64.50+0.62%€64.56€63.90292,271 shs$2.42 billion Related Companies: Biotest Aktiengesellschaft Stock Chart Evotec Stock Chart Gerresheimer Stock Chart CompuGroup Medical SE & Co. KGaA Stock Chart RHÖN-KLINIKUM Aktiengesellschaft Stock Chart Sartorius Aktiengesellschaft Stock Chart Carl Zeiss Meditec Stock Chart Medigene Stock Chart Genfit Stock Chart Stratec Stock Chart Receive MOR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter. This page (ETR:MOR) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersTrump is sounding the alarmPreserve GoldRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupThis 1 Biotech Stock has been shocking the marketsHuge AlertsDoes this make you sick?Allegiance GoldThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorBill Clinton Backing Biden Replacement???The Freeport SocietyThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MorphoSys AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.